What it is (overview)

A thyroid biopsy with imaging guidance (most often an ultrasound-guided thyroid biopsy) is a diagnostic procedure that removes a small sample of cells or tissue from the thyroid gland in the neck. The sample is then examined under a microscope by a pathologist to help determine whether a thyroid nodule or thyroid mass is benign (non-cancerous), malignant (cancerous), or needs further evaluation.

This test does not “measure” a hormone level like TSH or T4. Instead, it evaluates the cellular makeup of a thyroid nodule. Imaging guidance—typically ultrasound—helps the clinician place the needle precisely into the correct area of the nodule, which improves accuracy and reduces the chance of missing a suspicious spot (for example, a solid portion of a mixed cystic/solid nodule).

Results are usually reported in categories such as:

• Benign: Cells look non-cancerous. Many benign nodules are monitored with follow-up ultrasound rather than treated right away.

• Malignant or suspicious for malignancy: Findings suggest thyroid cancer, and your clinician will discuss next steps (often referral to endocrinology and/or surgery).

• Indeterminate/atypia/follicular lesion: Cells are not clearly benign or cancerous. Additional testing (repeat biopsy, molecular testing, or surgery) may be recommended depending on ultrasound features and risk factors.

• Non-diagnostic/insufficient: Not enough cells were obtained to make a reliable diagnosis. A repeat ultrasound-guided biopsy is commonly advised.

When & why it's usually done

A doctor may recommend a thyroid biopsy with imaging guidance when imaging or an exam suggests a nodule could be higher risk, or when a clear diagnosis is needed to guide treatment. It is most commonly ordered after a thyroid ultrasound detects one or more nodules with features that warrant sampling.

Common reasons include:

• A thyroid nodule found on ultrasound, CT, MRI, or PET scan: Many nodules are benign, but a biopsy may be needed based on size and ultrasound appearance.

• Suspicious ultrasound features: For example, irregular margins, microcalcifications, taller-than-wide shape, marked hypoechogenicity, or abnormal lymph nodes.

• Enlarging nodule or new neck lump: Growth over time may prompt biopsy, especially if the nodule becomes more solid or develops concerning features.

• Symptoms from a nodule or goiter: Pressure in the neck, trouble swallowing, hoarseness, a choking sensation, or breathing discomfort (biopsy helps determine if the cause is benign growth, inflammation, or cancer).

• Risk factors for thyroid cancer: History of radiation exposure to the head/neck (especially in childhood), a strong family history of thyroid cancer or certain genetic syndromes, or suspicious lymph nodes.

• Clarifying the cause of thyroid disease: In select cases, biopsy helps distinguish inflammatory conditions (like thyroiditis) from malignancy or other thyroid disease.

Imaging guidance is used because the thyroid sits close to important structures (blood vessels, trachea, nerves) and nodules can be small or deep. Ultrasound guidance improves safety and accuracy compared with “freehand” sampling.

Common diseases related to it

• Benign thyroid nodules (colloid nodules, hyperplastic nodules)
• Multinodular goiter
• Thyroid cysts (simple or complex cystic nodules)
• Thyroid cancer (papillary, follicular, medullary, anaplastic)
• Hashimoto’s thyroiditis (chronic autoimmune thyroiditis) and other forms of thyroiditis
• Follicular neoplasm / indeterminate thyroid nodule (requires further risk assessment)
• Thyroid lymphoma (rare, sometimes associated with long-standing Hashimoto’s)
• Metastatic disease to the thyroid (rare)

Health goals where it may help

• Cancer diagnosis and early detection for suspicious thyroid nodules
• Thyroid nodule evaluation to determine if a lump is benign or needs treatment
• Guiding treatment decisions (monitoring vs. surgery vs. additional testing)
• Monitoring thyroid health with follow-up planning after abnormal ultrasound findings
• Reducing unnecessary surgery by confirming benign disease when appropriate
• Endocrine system assessment as part of a broader workup for thyroid disease